Search results
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 5 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Philippe Laffont's Strategic Moves in Q1 2024: A Deep Dive into NVIDIA's Significant Reduction
GuruFocus.com via Yahoo Finance· 5 days ago:AAPL), selling all 2,444,368 shares, impacting the portfolio by -1.97%. Moderna Inc (NASDAQ:MRNA),...
Inducible deletion of microRNA activity in kidney mesenchymal cells exacerbates renal fibrosis -...
Nature· 7 days agoCompared with control mice, cKO mice had exacerbated interstitial fibrosis exhibited by immunofluorescence staining and mRNA expression of PDGFR-β. A microarray analysis showed ...
Josh Gottheimer's recent transactions in Adobe, Agree Realty, Alphabet and more By Investing.com
Investing.com· 4 days agoJosh Gottheimer, the representative for New Jersey's 5th congressional district, has made a series...
Repeat COVID-19 vaccinations elicit antibodies tha | Newswise
Newswise· 4 days agoThe COVID-19 pandemic is over, but the virus that caused it is still here, sending thousands of...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks· 7 days agoMerck (MRK) discontinues the Keytruda plus vibostolimab co-formulation arm of a phase III study due to a higher rate of patient discontinuation.
BofA cuts Schott Pharma shares target amid sales growth concern By Investing.com
Investing.com· 5 days agoThe adjustment follows the company's tempered expectations for sales growth and EBITDA margins for...
Josh Gottheimer's recent transactions in Adobe, Agree Realty, Alphabet and more By Investing.com
Investing.com· 4 days agoJosh Gottheimer's recent transactions in Adobe, Agree Realty, Alphabet and more
CDC new guidance: Schools should promote vaccines to prevent spread of infections
Florida Phoenix via Yahoo News· 3 days agoQuality Journalism for Critical Times The Centers for Disease Control and Prevention released new...
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
Digital Journal· 4 days agoIn addition, GEO-CM04S1 is in a Phase 2 clinical trial evaluating the vaccine as a more robust, durable Covid-19 booster among healthy patients who previously received the mRNA</ ...